Harvard Bioscience, Inc. (HBIO)

8.24 +0.11 (+1.35%) USD  |  NASDAQ  |  Oct 09, 16:00
More

Harvard Bioscience Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for HBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 12, 2026 --
August 11, 2026 --
May 13, 2026 --
May 12, 2026 --
April 21, 2026 --
March 12, 2026 --
January 08, 2026 --
November 07, 2025 --
November 06, 2025 --
September 10, 2025 --
August 11, 2025 --
May 13, 2025 --
May 12, 2025 --
April 14, 2025 --
April 09, 2025 --
March 24, 2025 --
March 12, 2025 --
November 25, 2024 --
Date Value
November 08, 2024 --
November 07, 2024 --
August 09, 2024 --
May 08, 2024 --
May 07, 2024 --
March 08, 2024 --
March 07, 2024 --
November 08, 2023 --
November 07, 2023 --
August 16, 2023 --
August 09, 2023 --
August 08, 2023 --
June 22, 2023 --
April 26, 2023 --
April 25, 2023 --
March 10, 2023 --
March 09, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Agilent Technologies, Inc. Upgrade
Bio-Rad Laboratories, Inc. Upgrade
Bruker Corp. Upgrade
Danaher Corp. Upgrade
Illumina, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade